Saniona targets FDA IND filing for SAN2465 by end-October 2026

Bitget2026/10/13 06:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Saniona plans to file an Investigational New Drug (IND) application with the US FDA for SAN2465 by end-October 2026, clearing the path for first-in-human testing.
The company is preparing a Phase 1 trial in healthy volunteers to assess safety, tolerability, pharmacokinetics, and pharmacodynamic biomarkers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Saniona AB published the original content used to generate this news brief on October 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Saniona targets FDA IND filing for SAN2465 by end-October 2026

You may also like

Crypto prices